Short Interest Alert: Most and least shorted sub-$2B healthcare stock at the end of October
at seekingalpha.com (Tue, 3-Nov 10:15 AM)
Biodexa reaches 100-patient milestone in Serenta Phase 3 FAP trial as futility analysis timing moves up
Market Chameleon (Wed, 14-Oct 10:26 AM)
